C. G. Van Arman

1.6k total citations
30 papers, 1.2k citations indexed

About

C. G. Van Arman is a scholar working on Pharmacology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. G. Van Arman has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 6 papers in Organic Chemistry and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. G. Van Arman's work include Inflammatory mediators and NSAID effects (8 papers), Hormonal Regulation and Hypertension (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). C. G. Van Arman is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Hormonal Regulation and Hypertension (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). C. G. Van Arman collaborates with scholars based in United States. C. G. Van Arman's co-authors include C. M. Kagawa, James A. Cella, John L. Humes, F. A. Kuehl, Robert W. Egan, George C. Beveridge, Edwin A. Risley, Edward A. Ham, A. J. Begany and D E Duggan and has published in prestigious journals such as Nature, Science and Circulation Research.

In The Last Decade

C. G. Van Arman

30 papers receiving 1.0k citations

Peers

C. G. Van Arman

PHARM

EDM

PHARM

K.I. Williams United Kingdom

E. Arrigoni‐Martelli Denmark

K. Crowshaw United States

H. Heath United Kingdom

J.E. Tateson United Kingdom

Rashida A. Karmali United States

Tsumoru Miyamoto Japan

Ann F. Welton United States

Lauren M. Cagen United States

W Dawson United Kingdom

K.I. Williams United Kingdom

C. G. Van Arman

357 ×0.9

PHARM

407 ×1.3

280 ×1.4

EDM

147 ×0.9

PHARM

123 ×0.9

Citations per year, relative to C. G. Van Arman C. G. Van Arman (= 1×) peers K.I. Williams

Countries citing papers authored by C. G. Van Arman

Since Specialization

Citations

This map shows the geographic impact of C. G. Van Arman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. G. Van Arman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. G. Van Arman more than expected).

Fields of papers citing papers by C. G. Van Arman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. G. Van Arman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. G. Van Arman. The network helps show where C. G. Van Arman may publish in the future.

Co-authorship network of co-authors of C. G. Van Arman

This figure shows the co-authorship network connecting the top 25 collaborators of C. G. Van Arman. A scholar is included among the top collaborators of C. G. Van Arman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. G. Van Arman. C. G. Van Arman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duggan, D E, et al.. (1977). Identification of the biologically active form of sulindac.. Journal of Pharmacology and Experimental Therapeutics. 201(1). 8–13. 115 indexed citations

Kuehl, F. A., John L. Humes, George C. Beveridge, C. G. Van Arman, & Robert W. Egan. (1977). Biologically active derivatives of fatty acids. Inflammation. 2(4). 285–294. 15 indexed citations

Kuehl, F. A., John L. Humes, Robert W. Egan, et al.. (1977). ChemInform Abstract: ROLE OF PROSTAGLANDIN ENDOPEROXIDE PGG2 IN INFLAMMATORY PROCESSES. Chemischer Informationsdienst. 8(17). 1 indexed citations

Arman, C. G. Van. (1975). Role of the kallikrein-kinin system in inflammation. Life Sciences. 16(5). 822–823. 2 indexed citations

Arman, C. G. Van, et al.. (1974). Experimental gouty synovitis caused by bacterial endotoxin adsorbed onto urate crystals. Arthritis & Rheumatism. 17(4). 439–449. 19 indexed citations

Arman, C. G. Van, George W. Nuss, & Edwin A. Risley. (1973). INTERACTIONS OF ASPIRIN, INDOMETHACIN AND OTHER DRUGS IN ADJUVANT-INDUCED ARTHRITIS IN THE RAT. Journal of Pharmacology and Experimental Therapeutics. 187(2). 400–414. 30 indexed citations

Arman, C. G. Van, et al.. (1970). INHIBITORY EFFECTS OF INDOMETHACIN, ASPIRIN AND CERTAIN OTHER DRUGS ON INFLAMMATIONS INDUCED IN RAT AND DOG BY CARRAGEENAN, SODIUM URATE AND ELLAGIC ACID. Journal of Pharmacology and Experimental Therapeutics. 175(2). 459–468. 46 indexed citations

Arman, C. G. Van & George W. Nuss. (1969). Plasma bradykininogen levels in adjuvant arthritis and carrageenan inflammation. The Journal of Pathology. 99(3). 245–250. 19 indexed citations

Arman, C. G. Van, et al.. (1965). SOME DETAILS OF THE INFLAMMATIONS CAUSED BY YEAST AND CARRAGEENIN (WITH APPENDIX ON KINETICS OF THE REACTION). Journal of Pharmacology and Experimental Therapeutics. 150(2). 328–334. 152 indexed citations

10.

Arman, C. G. Van, et al.. (1962). PHARMACOLOGY OF A NEW ANTIARRHYTHMIC AGENT, γ-DIISOPROPYL AMINO-α-PHENYL-α-(2-PYRIDYL)-BUTYRAMIDE (SC-7031). Journal of Pharmacology and Experimental Therapeutics. 136(1). 114–124. 23 indexed citations

11.

Arman, C. G. Van, et al.. (1961). SC-10049: A CATECHOLAMINE BRONCHODILATOR AND HYPERGLYCEMIC AGENT. Journal of Pharmacology and Experimental Therapeutics. 133(1). 90–97. 23 indexed citations

12.

Kagawa, C. M. & C. G. Van Arman. (1960). BROMIDE AND CHLORIDE EXCRETION WITH DIURETIC AGENTS IN ANIMALS. Journal of Pharmacology and Experimental Therapeutics. 129(3). 343–349. 4 indexed citations

13.

Kagawa, C. M., F. M. Sturtevant, & C. G. Van Arman. (1959). PHARMACOLOGY OF A NEW STEROID THAT BLOCKS SALT ACTIVITY OF ALDOSTERONE AND DESOXYCORTICOSTERONE. Journal of Pharmacology and Experimental Therapeutics. 126(2). 123–130. 62 indexed citations

14.

Kagawa, C. M. & C. G. Van Arman. (1958). Diuretic effects of formoguanamine and other s-triazines.. PubMed. 124(4). 318–23. 2 indexed citations

15.

Kagawa, C. M. & C. G. Van Arman. (1957). Sodium Retaining Activity of 19-Nor-Steroids in Adrenalectomized Rats. Experimental Biology and Medicine. 94(3). 444–447. 36 indexed citations

16.

Arman, C. G. Van. (1954). THE DIURETIC ACTIVITY OF ISOCYTOSINES. Journal of Pharmacology and Experimental Therapeutics. 111(3). 285–292. 6 indexed citations

17.

Sturtevant, F. M., et al.. (1954). The Temporal Course of Fluid Intake and Response to Fluid Loads in Perinephritic Hypertension in Rats. Circulation Research. 2(1). 73–78. 4 indexed citations

18.

Arman, C. G. Van. (1952). The Origin of Bradykinin. Experimental Biology and Medicine. 79(3). 356–359. 12 indexed citations

19.

Saunders, F. J., et al.. (1952). Mechanisms of Desoxycorticosterone Action. American Journal of Physiology-Legacy Content. 170(3). 486–497. 18 indexed citations

20.

Arman, C. G. Van. (1951). Amino Acids and Amines as Precursors of Epinephrine. American Journal of Physiology-Legacy Content. 164(2). 476–479. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact